Sophie Parmentier Batteur

Title: Sophie Parmentier Batteur: Innovator in Cognitive Disorder Treatments

Introduction

Sophie Parmentier Batteur is a notable inventor based in Haverford, PA (US). She has made significant contributions to the field of cognitive disorder treatments, holding a total of four patents. Her work focuses on the development of humanized antibodies that target specific proteins associated with cognitive disorders.

Latest Patents

Sophie’s latest patents include a humanized antibody for treating or preventing cognitive disorders, along with the process for producing the same. This invention provides methods for using and compositions of humanized antibodies that bind tau protein phosphorylated at the serine at position 413. Additionally, she has developed high affinity antibodies that specifically bind to human tau phosphorylated at serine 413. These patents also encompass compositions, kits, methods, and uses involving such antibodies or antigen binding fragments.

Career Highlights

Throughout her career, Sophie has worked with prominent companies such as Merck Sharp & Dohme Corporation and Teijin Pharma Limited. Her innovative work has positioned her as a key figure in the research and development of treatments for cognitive disorders.

Collaborations

Sophie has collaborated with notable coworkers, including Jeanne E Baker and Carl Mieczkowski. Their combined expertise has contributed to the advancement of her research and the successful development of her patents.

Conclusion

Sophie Parmentier Batteur is a pioneering inventor whose work in the field of cognitive disorders has the potential to make a significant impact on treatment options. Her innovative patents and collaborations highlight her dedication to advancing medical science.